Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nathan R Unger

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Surgical Infections|May 15, 2014
Effectiveness of pre-operative cefazolin in obese patientsNathan R Unger, Bradley J Stein
Antibiotics (Basel, Switzerland)|May 30, 2019
Statin Use and the Point Prevalence of Antibiotics in Ambulatory Patients with Diabetes in the National Health and Nutrition Examination Survey (NHANES) 2003-2012Sumaiah J Alarfaj, Alexandra Perez, Nathan R Unger
Pharmacotherapy|May 29, 2013
Penicillin skin testing: potential implications for antimicrobial stewardshipNathan R Unger, Timothy P Gauthier, Linda W Cheung
American Journal of Pharmaceutical Education|February 19, 2016
An Elective Course on Antimicrobial StewardshipTimothy P Gauthier, Elizabeth M Sherman, Nathan R Unger
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|April 2, 2014
Tedizolid: a new oxazolidinone antimicrobialJamie J Kisgen, Hanine Mansour, Nathan R Unger, et al.
Plos One|August 12, 2014
Antibiotic susceptibilities of bacteria isolated within the oral flora of Florida blacktip sharks: guidance for empiric antibiotic therapyNathan R Unger, Erich Ritter, Robert Borrego, et al.
Antibiotics (Basel, Switzerland)|March 31, 2016
Cost Reduction of Inhaled Tobramycin by Use of Preservative-Free Intravenous Tobramycin Given via InhalationTimothy P Gauthier, Justin Wasko, Nathan R Unger, et al.
Clinical Therapeutics|August 31, 2015
Cobicistat: Review of a Pharmacokinetic Enhancer for HIV InfectionElizabeth M Sherman, Marylee V Worley, Nathan R Unger, et al.
Expert Opinion on Pharmacotherapy|November 1, 2016
Elvitegravir for the treatment of HIVNathan R Unger, Marylee V Worley, Jamie J Kisgen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 20, 2014
Clinical infectious diseases pharmacists in the United States: a problem of both supply and demandTimothy P Gauthier, Marylee Worley, Vanesa Laboy, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Surgical Infections|May 15, 2014
Effectiveness of pre-operative cefazolin in obese patientsNathan R Unger, Bradley J Stein
Antibiotics (Basel, Switzerland)|May 30, 2019
Statin Use and the Point Prevalence of Antibiotics in Ambulatory Patients with Diabetes in the National Health and Nutrition Examination Survey (NHANES) 2003-2012Sumaiah J Alarfaj, Alexandra Perez, Nathan R Unger
Pharmacotherapy|May 29, 2013
Penicillin skin testing: potential implications for antimicrobial stewardshipNathan R Unger, Timothy P Gauthier, Linda W Cheung
American Journal of Pharmaceutical Education|February 19, 2016
An Elective Course on Antimicrobial StewardshipTimothy P Gauthier, Elizabeth M Sherman, Nathan R Unger
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|April 2, 2014
Tedizolid: a new oxazolidinone antimicrobialJamie J Kisgen, Hanine Mansour, Nathan R Unger, et al.
Plos One|August 12, 2014
Antibiotic susceptibilities of bacteria isolated within the oral flora of Florida blacktip sharks: guidance for empiric antibiotic therapyNathan R Unger, Erich Ritter, Robert Borrego, et al.
Antibiotics (Basel, Switzerland)|March 31, 2016
Cost Reduction of Inhaled Tobramycin by Use of Preservative-Free Intravenous Tobramycin Given via InhalationTimothy P Gauthier, Justin Wasko, Nathan R Unger, et al.
Clinical Therapeutics|August 31, 2015
Cobicistat: Review of a Pharmacokinetic Enhancer for HIV InfectionElizabeth M Sherman, Marylee V Worley, Nathan R Unger, et al.
Expert Opinion on Pharmacotherapy|November 1, 2016
Elvitegravir for the treatment of HIVNathan R Unger, Marylee V Worley, Jamie J Kisgen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 20, 2014
Clinical infectious diseases pharmacists in the United States: a problem of both supply and demandTimothy P Gauthier, Marylee Worley, Vanesa Laboy, et al.
Pageof 2